Association of direct-acting antiviral treatment with mortality among Medicare beneficiaries with hepatitis C Y Kalidindi, J Jung, R Feldman, T Riley JAMA network open 3 (7), e2011055-e2011055, 2020 | 53 | 2020 |
Impact of the 340B drug pricing program on cancer care site and spending in Medicare J Jung, WY Xu, Y Kalidindi Health services research 53 (5), 3528-3548, 2018 | 27 | 2018 |
Differences in spending on provider-administered chemotherapy by site of care in Medicare Y Kalidindi, J Jung, R Feldman The American journal of managed care 24 (7), 328, 2018 | 22 | 2018 |
The impact of integration on outpatient chemotherapy use and spending in Medicare J Jung, R Feldman, Y Kalidindi Health economics 28 (4), 517-528, 2019 | 13 | 2019 |
Association of direct-acting antiviral therapy for hepatitis C with after-treatment costs among Medicare beneficiaries J Jung, R Feldman, Y Kalidindi, T Riley JAMA network open 3 (6), e208081-e208081, 2020 | 10 | 2020 |
Cancer care spending and use by site of provider-administered chemotherapy in Medicare A Shooshtari, Y Kalidindi, J Jung The American journal of managed care 25 (6), 296, 2019 | 9 | 2019 |
Impact of hospice on spending and utilization among patients with lung cancer in Medicare Y Kalidindi, J Segel, J Jung American Journal of Hospice and Palliative Medicine® 37 (4), 286-293, 2020 | 5 | 2020 |
Low utilization of direct-acting antiviral agents in a large national cohort of HIV and HCV coinfected medicare patients in the United States: implications for HCV elimination P Du, J Jung, Y Kalidindi, K Farrow, T Riley III, C Whitener Journal of Public Health Management and Practice 28 (2), 130-134, 2022 | 3 | 2022 |
Impact of length of hospice on spending and utilization among medicare beneficiaries with lung cancer Y Kalidindi, J Jung, J Segel, D Leslie American Journal of Hospice and Palliative Medicine® 37 (11), 918-924, 2020 | 2 | 2020 |
Cancer care service use intensity in Medicare Advantage versus traditional Medicare. AP Mitchell, Y Kalidindi, R Feldman, C Carlin, G Song, J Jung Journal of Clinical Oncology 42 (16_suppl), 11054-11054, 2024 | | 2024 |
Lung cancer: Impact of hospice on healthcare costs and utilization Y Kalidindi | | 2020 |
1081 Direct-Acting Antiviral Therapy Against Hepatitis C in Patients With Liver Cancer: Is It Safe? MI Kang, J Jung, Y Kalidindi, T Riley Official journal of the American College of Gastroenterology| ACG 114, S611-S612, 2019 | | 2019 |
Impact of Biologics on the Use of Non-Drug Medical Services in Medicare A Shooshtari, Y Kalidindi, J Jung 2019 Annual Research Meeting, 2019 | | 2019 |
The authors respond and stand behind their findings. Y Kalidindi, J Jung, R Feldman The American journal of managed care 24 (10), 451-451, 2018 | | 2018 |